FF
ARKG icon

FourThought Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

FourThought Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3K Sell
100
-15
-13% -$551 ﹤0.01% 1237
2022
Q2 		$4K Buy
115
+15
+15% +$525 ﹤0.01% 1182
2022
Q1 		$5K Sell
100
-3
-3% -$143 ﹤0.01% 1178
2021
Q4 		$6K Sell
103
-79
-43% -$5.46K ﹤0.01% 1170
2021
Q3 		$13K Buy
+182
New +$15.3K ﹤0.01% 1043

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

FourThought Financial's ARKG Position: Q3 2022 in Review

FourThought Financial reduced its ARK Genomic Revolution ETF (ARKG) stake by 13% in Q3 2022, selling an estimated $551 and leaving 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.

FourThought Financial first reported a position in ARKG in Q3 2021 and has held it in 5 quarters since. The position peaked at $13K in Q3 2021. 312 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

  • FourThought Financial held 100 shares of ARK Genomic Revolution ETF worth $3K as of Q3 2022.
  • FourThought Financial sold 15 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $551.
  • ARK Genomic Revolution ETF made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1237 holding.
  • FourThought Financial first reported a position in ARK Genomic Revolution ETF in Q3 2021 and has held it in 5 quarters since.
  • FourThought Financial's ARK Genomic Revolution ETF position peaked at $13K in Q3 2021.
  • 312 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.